Oncologic Surgery and Perioperative Care
Research activity includes oncologic surgery with interest in reducing postoperative morbidity, managing inflammatory risk, and improving recovery after major cancer operations.
- Postoperative morbidity
- Inflammatory state
- Perioperative risk reduction
- Major oncologic surgery
Clinical work in this area also addresses patients undergoing complex surgical treatment for advanced abdominal and pelvic malignancies.
Genitourinary and Renal Cancers
The sponsor is active in bladder cancer, renal cell carcinoma, collecting duct carcinoma, renal medullary carcinoma, and metastatic thyroid cancer, with additional interest in refractory and pretreated disease.
- Muscle-invasive bladder cancer
- Renal cell carcinoma
- Collecting duct carcinoma
- Metastatic thyroid cancer
Its research also extends to advanced urothelial and non-urothelial histologies and to disease settings involving prior exposure to immune-based treatment.
Breast, Gynecologic, and Gastrointestinal Cancers
Key interests include triple negative breast cancer, endometrial cancer, ovarian cancer, cervical carcinoma, colorectal cancer, and rectal cancer, reflecting broad engagement across solid tumors in women’s and digestive oncology.
- Triple negative breast cancer
- Ovarian cancer
- Locally advanced cervical carcinoma
- Colorectal and rectal cancer
Research also covers high-risk disease after surgery and molecularly selected colorectal settings with persistent residual disease.
Thoracic, Neuroendocrine, and Rare Tumors
The portfolio includes non-small cell lung cancer, Merkel cell carcinoma, gastroenteropancreatic neuroendocrine tumors, thoracic neuroendocrine tumors, medulloblastoma, and diffuse intrinsic pontine glioma.
- Non-small cell lung cancer
- Merkel cell carcinoma
- Neuroendocrine tumors
- Pediatric brain tumors
This area also includes rare and aggressive cancers requiring specialized multidisciplinary management.
Lymphoma, Sarcoma, and Peritoneal Disease
Additional activity focuses on Hodgkin and non-Hodgkin lymphoma, mantle-cell lymphoma, peripheral T-cell lymphoma, soft tissue sarcoma, and pseudomyxoma peritonei.
- Relapsed or refractory lymphoma
- High-risk soft tissue sarcoma
- Pseudomyxoma peritonei
- Peritoneal metastases
Research in this group also includes conditions linked to advanced peritoneal spread and challenging relapsed hematologic malignancies.
